JP2009512700A5 - - Google Patents

Download PDF

Info

Publication number
JP2009512700A5
JP2009512700A5 JP2008536695A JP2008536695A JP2009512700A5 JP 2009512700 A5 JP2009512700 A5 JP 2009512700A5 JP 2008536695 A JP2008536695 A JP 2008536695A JP 2008536695 A JP2008536695 A JP 2008536695A JP 2009512700 A5 JP2009512700 A5 JP 2009512700A5
Authority
JP
Japan
Prior art keywords
composition
affinity labeling
labeling agent
animal
caspase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2008536695A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009512700A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2006/040047 external-priority patent/WO2007050319A1/en
Publication of JP2009512700A publication Critical patent/JP2009512700A/ja
Publication of JP2009512700A5 publication Critical patent/JP2009512700A5/ja
Withdrawn legal-status Critical Current

Links

JP2008536695A 2005-10-21 2006-10-12 アポトーシスのインビボ検出 Withdrawn JP2009512700A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72922705P 2005-10-21 2005-10-21
PCT/US2006/040047 WO2007050319A1 (en) 2005-10-21 2006-10-12 In vivo detection of apoptosis

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2013094397A Division JP2013165729A (ja) 2005-10-21 2013-04-26 アポトーシスのインビボ検出

Publications (2)

Publication Number Publication Date
JP2009512700A JP2009512700A (ja) 2009-03-26
JP2009512700A5 true JP2009512700A5 (cg-RX-API-DMAC7.html) 2009-10-08

Family

ID=37968120

Family Applications (3)

Application Number Title Priority Date Filing Date
JP2008536695A Withdrawn JP2009512700A (ja) 2005-10-21 2006-10-12 アポトーシスのインビボ検出
JP2013094397A Withdrawn JP2013165729A (ja) 2005-10-21 2013-04-26 アポトーシスのインビボ検出
JP2015160275A Pending JP2015204844A (ja) 2005-10-21 2015-08-17 アポトーシスのインビボ検出

Family Applications After (2)

Application Number Title Priority Date Filing Date
JP2013094397A Withdrawn JP2013165729A (ja) 2005-10-21 2013-04-26 アポトーシスのインビボ検出
JP2015160275A Pending JP2015204844A (ja) 2005-10-21 2015-08-17 アポトーシスのインビボ検出

Country Status (8)

Country Link
US (3) US8187573B2 (cg-RX-API-DMAC7.html)
EP (1) EP1946101A4 (cg-RX-API-DMAC7.html)
JP (3) JP2009512700A (cg-RX-API-DMAC7.html)
KR (1) KR101449507B1 (cg-RX-API-DMAC7.html)
AU (1) AU2006306592A1 (cg-RX-API-DMAC7.html)
CA (1) CA2626392A1 (cg-RX-API-DMAC7.html)
IL (1) IL190949A0 (cg-RX-API-DMAC7.html)
WO (1) WO2007050319A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2626392A1 (en) * 2005-10-21 2007-05-03 Immunochemistry Technologies, Llc In vivo detection of apoptosis
WO2016065174A1 (en) * 2014-10-22 2016-04-28 Seed Research And Development Llc Caspase probes for detection of apoptosis
WO2016090169A1 (en) * 2014-12-03 2016-06-09 Seed Research And Development Llc Intracellular caspase probes for detection of apoptosis and inflammation and kits containing such probes

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6756207B1 (en) * 1997-02-27 2004-06-29 Cellomics, Inc. System for cell-based screening
PL336571A1 (en) * 1997-04-30 2000-07-03 Univ Leland Stanford Junior Method of in vitro visualising the cellular death
EP1076563B1 (en) * 1998-03-16 2005-05-11 Cytovia, Inc. Dipeptide caspase inhibitors and the use thereof
CA2328457A1 (en) * 1998-06-20 1999-12-29 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
US6589503B1 (en) * 1998-06-20 2003-07-08 Washington University Membrane-permeant peptide complexes for medical imaging, diagnostics, and pharmaceutical therapy
AU5366499A (en) * 1998-08-19 2000-03-14 Ontario Cancer Institute, The The use of high frequency ultrasound imaging to detect and monitor the process of apoptosis in living tissues, (ex-vivo) tissues and cell-culture
WO2000042048A1 (en) * 1999-01-19 2000-07-20 Leif Robert C A reagent system and method for increasing the luminescence of lanthanide(iii) macrocyclic complexes
WO2001089584A2 (en) 2000-05-23 2001-11-29 Amersham Health As Contrast agents
IL145210A (en) * 2000-12-06 2011-12-29 Aposense Ltd Use of pmbc in the preparation of an agent for the selective binding of cells, a method for the detection of apoptosis and a pharmaceutical composition for the treatment of a disease characterized by the presence of apoptosis in cells, tissues or cellular structures
WO2003059877A2 (en) 2001-12-21 2003-07-24 Immunochemistry Technologies, Llc Novel affinity labels
WO2003060466A2 (en) 2001-12-21 2003-07-24 Immunochemistry Technologies, Llc Affinity labeling of serine proteases for simultaneous detection of multiple serine protease activity levels
WO2003058194A2 (en) 2001-12-21 2003-07-17 Immunochemistry Technologies, Llc Affinity labeling of enzymes for detection of enzyme activity level in living cells
AU2003272189A1 (en) 2002-04-05 2004-01-19 Cytovia, Inc. Caspase inhibitors for the treatment of diseases and conditions caused by exposure to radionuclides, biological agents, or chemical agents
IL153183A (en) * 2002-06-04 2010-05-17 Aposense Ltd Agents for imaging and diagnostic methods using them
US7056947B2 (en) * 2002-07-05 2006-06-06 Georgia Tech Research Corp. Aza-peptide epoxides
EP1594819A1 (en) 2003-02-07 2005-11-16 Merck Frosst Canada & Co. Irreversible caspase-3 inhibitors as active site probes
KR20050034922A (ko) 2003-10-10 2005-04-15 주식회사 엘지생명과학 2-알킬-4-옥소부타노일 그룹을 함유하는 케스페이즈저해제 및 그의 약제학적 조성물
GB0327494D0 (en) * 2003-11-26 2003-12-31 Amersham Plc Novel imaging agents
US20070082377A1 (en) * 2005-10-07 2007-04-12 Olin Michael R Cytotoxicity assays
CA2626392A1 (en) * 2005-10-21 2007-05-03 Immunochemistry Technologies, Llc In vivo detection of apoptosis

Similar Documents

Publication Publication Date Title
US7303741B2 (en) Systems and methods for high-resolution in vivo imaging of biochemical activity in a living organism
Rosenthal et al. The status of contemporary image-guided modalities in oncologic surgery
CN103402547B (zh) 开关型荧光纳米颗粒探针以及使用其的荧光分子成像法
CN101528267A (zh) 用于检测前列腺癌的造影剂
JP2019509252A (ja) 組織の区別、例えば、手術中の可視化のための、イメージングシステムおよび方法
AU2007249226A1 (en) Imaging agents and methods
US9783554B2 (en) Lanthanide ion complexes and imaging method
Li et al. Near‐Infrared Organic Room Temperature Phosphorescent Probes Targeting Fibroblast Activation Protein for Surgical Navigation of Liver Cancer
JP2009512700A5 (cg-RX-API-DMAC7.html)
KR100825939B1 (ko) 근적외선 형광체가 결합된 양친성 고분자의 나노 입자를포함하는 암 진단용 조영제
JP7086863B2 (ja) 触診可能なマーカー組成物
US20150093329A1 (en) In vivo detection of apoptosis
Song et al. Development of a tumor-targetable heteropolymetallic lanthanide-complex-based magnetoluminescent probe for dual-modal time-gated luminescence/magnetic resonance imaging of cancer cells in vitro and in vivo
JP2019513783A (ja) 病変標識用注射剤組成物
Bentrad et al. Advancement of Nanomaterials in the Biomedical Field for Disease Diagnosis
Min Specific targeting breast cancer and its metastatic lesions using light-emitting bacteria
AU2015272006A1 (en) In vivo detection of apoptosis
Berrens et al. Renal clearance of fluorescent agents can compromise image‐guided surgery along the urinary tract
DE102006035577A1 (de) Röntgendichtes Konjugat
JP2023537627A (ja) 腫瘍検出及びサージカルガイダンスのための化合物及び組成物
CN118806935A (zh) 靶向弹性蛋白的血管造影剂
Kang et al. Application of Near Infrared Fluorescence Bioimaging in Nanosystems
Bornhop et al. Fluorescent probes in biomedical applications
Vo-Dinh Fluorescent Probes in Biomedical Applications
Peng et al. Intraoperative near-infrared imaging for precise resection of bladder cancer by αvβ3 targeting fluorescent agent